World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
55
Citations
9932
World Ranking
3816
National Ranking
146

Stefan Nierkens publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stefan Nierkens sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 255 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stefan Nierkens D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stefan Nierkens sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 55 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stefan Nierkens is affiliated with the University Medical Center Utrecht in the Netherlands. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with particular focus on Immunology, Hematology, and Oncology as significant subfields.

Their main research topics include hematopoietic stem cell transplantation, CAR-T cell therapy research, immune cell function and interaction, acute myeloid leukemia research, T-cell and B-cell immunology, acute lymphoblastic leukemia research, and immunotherapy and immune responses.

Stefan Nierkens has contributed to publications in several scientific venues, with frequent publications appearing in bioRxiv (Cold Spring Harbor Laboratory), Blood, Cancers, Frontiers in Immunology, and Neuro-Oncology. These venues reflect a focus on immunology, hematology, oncology, and related biomedical sciences.

Recent papers authored or co-authored by Stefan Nierkens include:

  • MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy, 2020, Cancers
  • The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology, 2020, European Journal of Cancer
  • Uncovering the mode of action of engineered T cells in patient cancer organoids, 2022, Nature Biotechnology
  • Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers, 2020, Journal of Allergy and Clinical Immunology
  • Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis, 2021, Journal of Investigative Dermatology

They have collaborated frequently with several co-authors, including Caroline A. Lindemans, Jaap Jan Boelens, Eveline M. Delemarre, Annelisa M. Cornel, and Mirjam E. Belderbos. These collaborations suggest ongoing research efforts in immunology and hematology-related projects.

Best Publications

  • MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy.

    Annelisa M. Cornel;Iris L. Mimpen;Stefan Nierkens

  • Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity

    M H M G M den Brok;R P M Sutmuller;S Nierkens;E J Bennink

  • Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

    W. Joost Lesterhuis;Cornelis J.A. Punt;Stanleyson V. Hato;Dagmar Eleveld-Trancikova

  • Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?

    Joannes F M Jacobs;Stefan Nierkens;Carl G Figdor;I Jolanda M de Vries

  • CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.

    Oliver M. Grauer;Stefan Nierkens;Erik Bennink;Liza W.J. Toonen

  • Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors

    Joannes F.M. Jacobs;Albert J. Idema;Kalijn F. Bol;Stefan Nierkens

  • Synergy between In situ Cryoablation and TLR9 Stimulation Results in a Highly Effective In vivo Dendritic Cell Vaccine

    Martijn H.M.G.M. den Brok;Roger P.M. Sutmuller;Stefan Nierkens;Erik J. Bennink

  • Uncovering the mode of action of engineered T cells in patient cancer organoids

    Unknown

  • Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis

    Rick Admiraal;Rick Admiraal;Stefan Nierkens;Moniek A de Witte;Eefke J Petersen

  • Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation.

    Rick Admiraal;Caroline A. Lindemans;Charlotte van Kesteren;Marc B. Bierings

  • The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology.

    Judith Wienke;Miranda P. Dierselhuis;Godelieve A.M. Tytgat;Annette Künkele

  • TLR ligands in the local treatment of established intracerebral murine gliomas.

    Oliver M. Grauer;Johan W. Molling;Erik Bennink;Liza W. J. Toonen

  • Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis.

    Judith L. Thijs;Ian Strickland;Carla A.F.M. Bruijnzeel-Koomen;Stefan Nierkens

  • Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?

    Stefan Nierkens;Jurjen Tel;Edith Janssen;Gosse J. Adema

  • Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.

    Stefan Nierkens;Martijn H. den Brok;Zacharias Garcia;Susan Togher

  • Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations

    Joris M. Van Montfrans;Esther A. R. Hartman;Kees P. J. Braun;Eric A. M. Hennekam

  • Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry.

    Lieneke F M Ariëns;Jorien van der Schaft;Daphne S Bakker;Deepak Balak

  • Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation

    Rick Admiraal;Coco C.H. de Koning;Caroline A. Lindemans;Marc B. Bierings

  • Toll-like receptor signalling on Tregs: to suppress or not to suppress?

    Wendy W C van Maren;Joannes F M Jacobs;I Jolanda M de Vries;Stefan Nierkens

  • Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate‐pulsed dendritic cells in a murine glioma model

    Oliver M. Grauer;Roger P.M. Sutmuller;Roger P.M. Sutmuller;Wendy van Maren;Joannes F.M. Jacobs

  • Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations

    J Van Montfrans;E Hartman;K Braun;F Hennekam

Frequent Co-Authors

Gosse J. Adema
Gosse J. Adema Radboud University
Raymond Pieters
Raymond Pieters Utrecht University
Edward F. Knol
Edward F. Knol Utrecht University
Louis Boon
Louis Boon University of Amsterdam
Marianne Boes
Marianne Boes Utrecht University
Carl G. Figdor
Carl G. Figdor Radboud University
Timothy R D J Radstake
Timothy R D J Radstake Utrecht University
Leo Koenderman
Leo Koenderman Utrecht University
Guillermo Sanz
Guillermo Sanz Hospital Universitari i Politècnic La Fe

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, there are several online degree options that can complement your expertise and expand your career opportunities. Healthcare professionals, especially nurses, often pursue advanced degrees such as Psychiatric Nurse Practitioner (PMHNP) programs. Exploring the best pmhnp programs online can help you find courses that offer strong clinical placements, crucial for practical experience.

Affordability is another key consideration. Many prospective students look for cost-effective paths, making the cheapest psychiatric nurse practitioner programs highly appealing. These programs help balance quality education with budget constraints.

Salary outlooks also influence career decisions. Those holding a Doctor of Nursing Practice (DNP) degree can refer to resources like the dnp salary guide to understand earning potential across different states, aiding in informed career planning.

Finally, transitioning roles is common in nursing careers. For example, moving from a Family Nurse Practitioner (FNP) to an Acute Care NP often requires additional certification. The fnp to acute care np bridge program is an excellent resource for nurses looking to make this shift smoothly.

Best Scientists Citing Stefan Nierkens

Trending Scientists

Recently Published Articles